2024 / 01

Next Paper
DOI: 10.47183/mes.2024.012

ORIGINAL RESEARCH

Association of GSTP1 gene with renal function in patients with diabetes mellitus

Kostyushok NYa1, Gornov SV1, Sizov AV2
About authors

1 Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical Biological Agency, Moscow, Russia

2 Federal Research and Clinical Center of Medical Rehabilitation and Balneology of the Federal Medical Biological Agency, Moscow, Russia

Correspondence should be addressed: Nadezhda Ya. Kostyushok
Sedina, 4, Krasnodar, 350063, Russia; ur.tsil@NavolagahS

About paper

Author contribution: Kostyushok NYa — preparation of tests, experimental procedure, analysis of the results; Gornov SV — research management, manuscript editing; Sizov AV — manuscript revision.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Kuban State Medical University (protocol № 91 dated 29 September 2020). All patients submitted the informed consent to study participation.

Received: 2024-01-25 Accepted: 2024-03-15 Published online: 2024-03-28
|
  1. Ivanets NV. Nauchnoe obosnovanie sovershenstvovaniya upravleniya deyatel'nost'yu tsentralizovannoy kliniko-diagnosticheskoy laboratorii [dissertation]. Natsional'nyy nauchno-issledovatel'skiy institut obshchestvennogo zdorov'ya RAMN, 2015. Russian.
  2. Paltsev MA. Personalizirovannaya meditsina. Nauka v Rossii. 2011; 1: 12–7. ISSN 0869-7078. Russian.
  3. Bibikova VV, Emanuel VL. Current Status of Specialized Clinical Laboratory and its Role in Facilitating a Transition Towards Personalized Medicine. Laboratory Service. 2020; 9 (3): 16–23. Russian.
  4. Heerspink HJ, Cherney DZ, Groop PH, Matthieu C, Rossing P, Tuttle KR. People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action. The Lancet Diabetes & Endocrinology. 2023; 11 (8): 536–40.
  5. Asfandiyarova NS. A review of mortality in type 2 diabetes mellitus. Diabetes mellitus. 2015; 18 (4): 12–21. DOI: 10.14341/DM6846. Russian.
  6. Rawshani A, Sattar N, Franzén S, McGuire DK, Eliasson B. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2019; 139 (16): 1900–12.
  7. De Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022; 45 (12): 3075–90. DOI: 10.1016/j.kint.2022.08.012.
  8. Piani MIF, Tommerdahl KL, Severn C, Chung LT, MacDonald A, et al. Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: results from the diabetic kidney alarm (DKA) study. Journal of Diabetes and its Complications. 2022; 36 (6): 108203. DOI: 10.1016/j.jdiacomp.2022.108203.
  9. Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MА. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017. Diabetes mellitus. 2018; 21 (3): 144–59. Russian.
  10. Shestakova МV. Diabetes mellitus and chronic kideny disease: modern diagnostics and treatment. Annals of the Russian Academy of Medical Sciences. 2012; 67 (1): 45–9. Russian.
  11. Illarioshkin SN. Modern view on etiology of parkinson's disease. Nevrologicheskiy zhurnal. 2015; 20 (4): 4–13. Russian.
  12. Liu D Liu Y, Ran L, Shang H, Li D. GSTT1 and GSTM1 polymorphisms and prostate cancer risk in Asians: a systematic review and meta-analysis. Tumor Biology. 2013; 34: 2539–44.
  13. Santric V, Djokic M, Suvakov S, Pljesa-Ercegovac M, Nikitovic M, Radic T, et al. GSTP1 rs1138272 polymorphism affects prostate cancer risk. Medicina. 2020; 56 (3): 128.
  14. ZamekGliszczynski MJ, Giacomini KM, Zhang L. Emerging clinical importance of hepatic organic cation transporter 1 (OCT1) in drug pharmacokinetics, dynamics, pharmacogenetic variability, and drug interactions. Clinical Pharmacology & Therapeutics. 2018; 5: 758–60.
  15. Mogilenkova LA, Rembovskiy VR. Role of genetic polymorphism and differences in the detoxification of chemical substances in the human body. Hygiene and Sanitation. 2016; 95 (3): 255–62. Russian.
  16. Westphal C, Konkel A, Schunck WH. Cytochrome p450 enzymes in the bioactILE/VALation of polyunsaturated Fatty acids and their role in cardiovascular disease. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450. 2015; 151–87.
  17. Sirota TV. Novyy podkhod v issledovanii protsessa autookisleniya adrenalina i ispol'zovanie ego dlya izmereniya aktivnosti superoksiddismutazy. Voprosy meditsinskoy khimii. 1999; 45 (3): 263–72. Russian.
  18. Korolyuk MA, Ivanova LI, Mayorova IG, Tokarev VE. Metod opredeleniya aktivnosti katalazy. Laboratornoe delo. 1988; 1: 16–9. Russian.
  19. Karpishchenko AI. Medical laboratory technologies and diagnostics: Guide. Vol. 2: Medical laboratory technologies. St. Petersburg: Intermedica, 1999; p. 792.
  20. Stalnaya ID, Garishvili TG, 1977. Method of determination of malonic dialdehyde using thiobarbityric acid. In: Modern methods in biochemistry. M.: Medicine, 1977; p. 66–8.
  21. Kostyushok NY, Pavlyuchenko II, Ivanova LA, Prozorovskaya YI. The role of the gene of the second phase of the xenobiotic biotransformation system gstp1 (ile105val) in the development of diabetic nephropathy in patients with type 2 diabetes mellitus. Modern problems of science and education. 2022; 4. Available from: https://science-education.ru/ru/article/view?id=31902. Russian.
  22. National Center for Biotechnology Information: Single Nucleotide Polymorphism Database (1998). Available from: https://www.ncbi.nlm.nih.gov/snp/.
  23. Stoian A, Bănescu C, Bălaşa RI, Moţăţăianu A, Stoian M, Moldovan VG, et al. Influence of GSTM1, GSTT1, and GSTP1 polymorphisms on type 2 diabetes mellitus and diabetic sensorimotor peripheral neuropathy risk. Disease markers. 2015; 2015: 638693.
  24. Agrawal S, Tripathi G, Khan F, Sharma R, Baburaj VP, et al. Relationship between GSTs gene polymorphism and susceptibility to end stage renal disease among North Indians. Renal failure. 2007; 29 (8): 947–53.
  25. Vojtková J, Ďurdík P, Čiljaková M, Michnová Z, Turčan T, Babušíková E. The association between glutathione S-transferase T1 and M1 gene polymorphisms and cardiovascular autonomic neuropathy in Slovak adolescents with type 1 diabetes mellitus. Journal of Diabetes and its Complications. 2013; 27 (1): 44–8.
  26. Perova NV, Drapkina OM. Triglitseridy: struktura, metabolizm, fiziologicheskie funktsii. M.: OOO «Vidoks», 2021; p. 192. Russian.